Experimental Heart Disease Drug Shows No Benefit in Clinical Trial
Audio narration · Coming soon
An experimental drug designed to lower a common risk factor for heart attacks was expected to improve patient survival. However, clinical results revealed that the medicine made no difference in patient outcomes. This unexpected failure challenges assumptions about the treatment's effectiveness.
Why this matters
PRISM scored this story 55/100 for interest.
Originally published by npr